Abstract
Background Inappropriate use of clonazepam by older adults is associated with cognitive impairment, delirium, and falls. Strategies to optimize its use are important to increase patient safety. Objective To evaluate the feasibility of a clonazepam deprescription protocol in the elderly. Methods This is a quasi-experimental study. Elderly people with chronic use of clonazepam and attended in primary care units in two Brazilian municipalities were selected. A deprescription protocol was used, which included five fortnightly meetings between the older adults and the research team, to reduce the dose by 25%. Patients received instructions on sleep hygiene behaviors and the advantages of clonazepam deprescription; family physicians followed a flowchart for gradual dose reduction. In the 1st and 5th meetings, there were medical appointments for anamnesis and discharge. The monitoring of patients and the application of tests were carried out by the research team. Results Of the 35 elderly people included in the study, 27 reached the end; 81.5% achieved deprescription: 22.2% stopped completely and 59.3% decreased the dose. At the last meeting, 20% of elderly patients reported an increase in blood pressure. Conclusion The high rate of deprescription and the little relevance of clonazepam withdrawal reactions, showed that the use of the protocol was effective. However, the increase in blood pressure and the worsening of sleep quality in the last meeting show the need for adjustment in the last stage of the deprescription process.
Similar content being viewed by others
References
Miranda GMD, Mendes ACG, Silva ALA. O envelhecimento populacional brasileiro: desafios e consequências sociais atuais e futuras. Rev Bras Geriatr Gerontol. 2016;19(3):507–19. https://doi.org/10.1590/1809-98232016019.150140.
Oliveira AS. Transição demográfica, transição epidemiológica e envelhecimento populacional no Brasil. Hygeia Rev Bras Geogr Méd Saúde. 2019;15(32):69–79. https://doi.org/10.14393/Hygeia153248614.
Malta DC, Stopa SR, Szwarcwald CL, et al. A vigilância e o monitoramento das principais doenças crônicas não transmissíveis no Brasil – pesquisa nacional de saúde, 2013. Rev Bras Epidemiol. 2015;18(2):3–16. https://doi.org/10.1590/1980-5497201500060002.
Brasil. Ministério da Saúde. Secretaria de Atenção Primária à Saúde [página da internet]. O que é Atenção Primária à Saúde? Brasília, DF. https://aps.saude.gov.br/smp/smpoquee. Accessed from 29 Sep 2021.
Baldoni AO, Chequer FMD, Ferraz ERA, et al. Elderly and drugs: risks and necessity of rational use. Braz J Pharm Sci. 2010;46(4):617–32. https://doi.org/10.1590/S1984-82502010000400003.
Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151(9):1825–32. https://doi.org/10.1001/archinte.1991.00400090107019.
Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med. 1997;157(4):1531–6. https://doi.org/10.1001/archinte.1997.00440350031003.
Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.
American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Societ updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31. https://doi.org/10.1111/j.532-5415.2012.03923.x.
American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46. https://doi.org/10.1111/jgs.13702.
American Geriatrics Society 2019 Beers Criteria® Update, Expert Panel. American geriatrics society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94. https://doi.org/10.1111/jgs.15767.
Oliveira MG, Amorim WW, Oliveira CRB, et al. Consenso Brasileiro de medicamentos potencialmente inapropriados para idosos. Geriatr Gerontol Aging. 2016;10(4):168–81. https://doi.org/10.5327/Z2447-211520161600054.
Control NIB. Report of the international narcotics control board for 2017. 2018. https://www.incb.org/documents/Publications/AnnualReports/AR2017/Annual_Report/E_2017_AR_ebook.pdf . Accessed from 31 Mar 2020.
Brasil. Ministério da Saúde. Secretaria de ciência, tecnologia e insumos estratégicos. Departamento de Assistência farmacêutica e insumos estratégicos. uso de medicamentos e medicalização da vida: recomendações e estratégias. [recurso eletrônico]/Ministério da Saúde secretaria de ciência tecnologia e insumos estratégicos departamento de assistência farmacêutica e insumos estratégicos – Brasília: Ministério da Saúde 2018. p. 33 http://bvsms.saude.gov.br/bvs/publicacoes/medicamentos_medicalizacao_recomendacoes_estrategia_1ed.pdf Accessed from 31 Mar 2020.
Xing D, Ma XL, Ma JX, et al. Association between use of benzodiazepines and risk of fractures: a meta-analysis. Osteoporos Int. 2014;25:105–20. https://doi.org/10.1007/s00198-013-2446-y.
Richardson K, Bennett K, Kenny RA. Polypharmacy including falls risk-increasing medications and subsequent falls in community. Age Ageing. 2015;44(1):90–6. https://doi.org/10.1093/ageing/afu141.
Naloto DCC, Lopes FC, Barberato-Filho SL, et al. Prescrição de benzodiazepínicos para adultos e idosos de um ambulatório de saúde mental. Ciênc Saúde Colet. 2016;21(4):1267–76. https://doi.org/10.1590/1413-81232015214.10292015.
Billioti de Gage S, Bégaud B, Bazin F, et al. Benzodiazepine use and risk of dementia: prospective. BMJ. 2012;345:e6231. https://doi.org/10.1136/bmj.e6231.
Rosenberg K. Benzodiazepine use increases Alzheimer’s risk. AJN. 2015;115(1):56.
Medronho RA, Bloch KV, Luiz RR, et al. Epidemiologia. 2nd ed. São Paulo: Atheneu; 2009. ISBN: 978-85-7379-999-6
Instituto Brasileiro de Geografia Estatítica. Panorama cidades: divinópolis. 2020. https://cidades.ibge.gov.br/brasil/mg/divinopolis. Accessed from 04 Apr 2020.
Instituto Brasileiro de Geografia Estatítica. Panorama cidades: itaúna. 2020. https://cidades.ibge.gov.br/brasil/mg/itauna/panorama. Accessed from 04 Apr 2020.
Smith WT, Londborg PD, Glaudin V, et al. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. Am J Psychiatry. 1998;155(10):1339–45. https://doi.org/10.1176/ajp.155.10.1339.
Grushka M, Epstein J, Mott A. An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86(5):557–61. https://doi.org/10.1016/s1079-2104(98)90345-6.
Brucki SMD, Nitrini R, Caramelli P, Bertolucci PHF, Okamoto IH. Sugestões para o uso do miniexame do estado mental no Brasil. Arq Neuropsiquiatr. 2003;61(3B):777–81.
Farrell B, Pottie K, Rojas-Fernandez CH, Bjerre LM, Thompson W, Welch V. Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing. PLoS ONE. 2016;11(8):1–12.
Baldoni AO, Zadra PF, Vilar LG, et al. Elaboração e validação do protocolo de desprescrição do clonazepam em idosos. RBMFC. 2020;15(42):1–14. https://doi.org/10.5712/rbmfc15(42)2105.
Bertolazi AN, Fagondes SC, Hoff LS, et al. Validation of the Brazilian Portuguese version of the Pittsburgh sleep quality index. Sleep Med. 2011;12(1):70–5. https://doi.org/10.1016/j.sleep.2010.04.020.
Silveira MB, Saldanha RP, Leite JCC, et al. Construction and validation of content of one instrument to assess falls in the elderly. Einstein (Sao Paulo). 2018;16(2):eAO4154. https://doi.org/10.1590/S1679-45082018AO4154.
Fleck MPA, Louzada S, Xavier M, et al. Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida “WHOQOL-bref.” Rev Saúde Públ. 2000;34(2):178–83. https://doi.org/10.1590/S0034-89102000000200012.
Bichara IM, Vilar L, Zadra P, et al. Educação e medidas não farmacológicas que promovam a qualidade do sono em idosos. Rev Bras Ext Univ. 2019;10(1):35–42. https://doi.org/10.24317/2358-0399.2019v10i1.8214.
Tyrer P, Murphy S, Riley P. The benzodiazepine withdrawal symptom questionnaire. J Affect Disord. 1990;19:53–61. https://doi.org/10.1016/0165-0327(90)90009-W.
Durbin K. Clonazepam: overview. In: Drugs.com [Internet]. Cerner Multum, Inc. 2018. https://www.drugs.com/clonazepam.htm. Accessed from 06 Apr 2020.
Bourgeois J, Elseviers MM, Van Bortel L, et al. Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study. Eur J Clin Pharmacol. 2014;70(10):1251–60. https://doi.org/10.1007/s00228-014-1725-7.
Vicens C, Sempere E, Bejarano F, et al. Efficacy of two interventions on the discontinuation of benzodiazepines in long-term users: 36-month follow-up of a cluster randomised trial in primary care. Br J Gen Pract. 2016;66(643): e8591. https://doi.org/10.3399/bjgp16X683485.
Garzón C, Guerrero JM, Aramburu O, et al. Effecf of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study. Aging Clin Exp Res. 2009;21(1):38–42. https://doi.org/10.1007/BF03324897.
Votaw VR, Geyer R, Rieselbach MM, et al. The epidemiology of benzodiazepine misuse: a systematic review. Drug Alcohol Depend. 2019;200:95–114. https://doi.org/10.1016/j.drugalcdep.2019.02.033.
Coutinho ESFS, Dutra S. Uso de medicamentos como fator de risco para fratura grave decorrente de queda em idosos. Cad Saude Publ. 2002;18(5):1359–66. https://doi.org/10.1590/S0102-311X2002000500029.
Marron L, Segurado R, Kenny RA, et al. The association between benzodiazepine use and falls, and the impact of sleep quality on this association: data from the TILDA study. QJM. 2020;113(1):31–6. https://doi.org/10.1093/qjmed/hcz217.
McDonald EM, Caslangen J. Benzodiazepine use and falls in older adults: is it worth the risk? Res Gerontol Nurs. 2019;12(5):214–6. https://doi.org/10.3928/19404921-20190813-01.
Lenander C, Bondesson A, Viberg N, et al. Effects of medication reviews on use of potentially inappropriate medications in elderly patients; A cross-sectional study in Swedish primary care. BMC Health Serv Res. 2018;18(1):1–9. https://doi.org/10.1186/s12913-018-3425-y.
Van Strien AM, Koek HL, Van Marum RJ, et al. Psychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderly. Maturitas. 2013;74(4):357–62. https://doi.org/10.1016/j.maturitas.2013.01.004.
Brunton L, Hilal-Dandan R, Knollmann B. As bases farmacológicas da terapêutica de goodman e Gilman. 13ª ed. Porto Alegre: AMGH Editora LTDA; 2018. ISBN: 8580556147
Chen TT, Ko CH, Chen ST, et al. Severity of alprazolam dependence and associated features among long-term alprazolam users from psychiatric outpatient clinics in Taiwan. J Formos Med Assoc. 2015;114(11):1097–104. https://doi.org/10.1016/j.jfma.2014.04.004.
Gupta S, Garg B. A case of etizolam dependence. Indian J Pharmacol. 2014;46:655–7. https://doi.org/10.4103/0253-7613.144943.
Rickels K, Case W, Schweizer E. The drug treatment of anxiety. Stress Health. 1988;4:231–9. https://doi.org/10.1002/smi.2460040408.
Longo LP, Johnson B. Addiction: part I. Benzodiazepines – side effects, abuse risck and alternatives. Am Fam Physician. 2000;61(7):2121–8.
Curran HV, Collins R, Fletcher S, et al. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med. 2003;33(7):1223–37. https://doi.org/10.1017/s0033291703008213.
Santos SLF, Almeida RDO, Paiva CEQ, et al. Serviço de atendimento farmacêutico ao idoso: relato de experiência de educação em saúde. Saúde (Sta Maria). 2016;42(2):225–31. https://doi.org/10.5902/2236583421522.
Salonoja M, Salminen M, Aarnio P, et al. One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons. Age Ageing. 2010;39(3):313–9. https://doi.org/10.1093/ageing/afp255.
Marques LAM, Nogueira VAS, Tiengo A. Avaliação do uso de benzodiazepínicos por clientes de uma drogaria privada. Rev Univ Vale do Rio Verde. 2013;11(1):234. https://doi.org/10.5892/813.
Souza ARL, Opaleye ES, Noto AR. Contextos e padrões do uso indevido de benzodiazepínicos entre mulheres. Cienc Saúde Colet. 2013;18(4):1131–40. https://doi.org/10.1590/S1413-81232013000400026.
Acknowledgements
Not applicable.
Funding
This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil (CAPES)—Finance Code 001.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
da Silva, L.G.R., da Silva Pinto, A.W., de Queiroz, W.E. et al. Deprescribing clonazepam in primary care older patients: a feasibility study. Int J Clin Pharm 44, 489–498 (2022). https://doi.org/10.1007/s11096-021-01371-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-021-01371-7